In this issue:
Pharmacogenetics-informed tricyclic antidepressant dosing in major depression
Zuranolone for major depression
Long-term suicidal ideation/behaviour of older adults with depression
Intravenous ketamine vs. intranasal esketamine for treatment-remission depression
Addition of intramuscular scopolamine to antidepressants in depression
Associations between depression, COPD, allergy & multimorbidity
Prevalence in mental health disorders from 2007-09 to 2019-22
Antidepressants & quality of life in major depression
Treatment resistance & outcome/course of ECT for major depression
Factors associated with early vs. late response to ECT
Please login below to download this issue (PDF)